comparemela.com

Latest Breaking News On - Ankylosing spondylitis disease activity score - Page 9 : comparemela.com

Positive Top-Line Results for Bimekizumab in Phase 3 Ankylosing Spondylitis Trial

Peripheral Manifestations Influence Spondyloarthritis Trajectory

MRI sacroiliitis, HLA-B27 predict long-term response to certolizumab pegol in axial SpA

In patients with non-radiographic axial spondyloarthritis, MRI sacroiliitis and HLA-B27 positivity, but not elevated C-reactive protein or responses at week 12, predict long-term certolizumab pegol response, according to data. “Non-radiographic axial spondyloarthritis can be a challenging diagnosis in the absence of radiographic sacroiliitis and selecting patients for treatment with

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.